Close

News

Rhenus Air & Ocean gains GDP certification at Schiphol Airport

Rhenus Air & Ocean’s pharma-focused business site at Amsterdam Airport Schiphol (AMS) has gained the Good Distribution Practice (GDP) certificate. The Dutch headquarters of Rhenus, which has been IATA CEIV Pharma accredited for years, follows the footsteps of the business...

Ceapro Inc. Receives Approval from Health Canada to Commence Phase 1/2a Human Clinical Trial Assessing Avenanthramide Tablets

Ceapro Inc., a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced it has received approval from Health Canada to initiate its Phase 1/2a study evaluating the safety, tolerability, bioavailabilty...

KangaBio and Aton Biotech Enter Into Development and Manufacturing Strategic Collaboration

Aton Biotech, a CDMO committed to enabling new biological drugs for clients with an integrated bio-pharmaceutical platform, and KangaBio have announced a strategic collaboration. Both parties aim to share resources and achieve joint development on the principle of equality and...

Lilly and ProQR to Expand RNA Editing Collaboration

Eli Lilly and Company and ProQR Therapeutics N.V. announced the expansion of their licensing and collaboration agreement focused on the discovery, development and commercialization of new genetic medicines. The collaboration, originally announced in September 2021, applied ProQR’s proprietary Axiomer® RNA editing...

Berkshire Sterile Manufacturing Expands Testing & Development Capabilities

Berkshire Sterile Manufacturing (BSM), a Massachusetts-based fill finish CDMO, recently purchased and validated three new analytical instruments to expand its testing and development capabilities. While the company’s primary service offering is sterile filtration and filling of parenterals, BSM also provides...

Micro-Sphere Launches R&D Lab in Switzerland

Global contract development and manufacturing organization Micro-Sphere has launched a new, 200 square-foot research and development (R&D) lab to strengthen its services in formulation development and inhalation. Located within its facility in Monteggio, Switzerland, the new R&D department will specialize...

Asymchem Opens New R&D Site Near Boston

Asymchem Laboratories (Tianjin) Co. Ltd., a CDMO serving the global pharmaceutical and biotech industry, has opened a new site in Woburn, Massachusetts. Asymchem Boston, a wholly owned subsidiary of Asymchem Group, marks an important step toward expanding Asymchem's global footprint....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read